Kallikrein-4
Kallikrein-4 (125-139) is a synthetic peptide fragment derived from the human kallikrein-4 protein, a serine protease implicated in diverse physiological processes including extracellular matrix remodeling, tissue homeostasis, and cancer biology. The 125-139 sequence represents a defined region within the mature enzyme, making it a valuable molecular tool for dissecting the structure-function relationships and substrate specificity of kallikrein-4. Due to its precise amino acid composition and relevance to protease activity, this peptide is frequently utilized in experimental systems aimed at elucidating the biochemical pathways involving kallikrein family members, as well as in the development of analytical assays and interaction studies.
Enzyme substrate studies: As a defined peptide segment corresponding to a functionally significant region of kallikrein-4, this product serves as an ideal substrate or competitive inhibitor in in vitro protease assays. Researchers employ it to investigate the enzymatic activity, catalytic efficiency, and substrate recognition properties of kallikrein-4 and related serine proteases. Such studies are critical for mapping cleavage sites, understanding substrate preferences, and evaluating the impact of post-translational modifications or sequence variants on proteolytic function.
Protein-protein interaction analysis: The peptide enables detailed examination of molecular interactions between kallikrein-4 and its binding partners. By incorporating the 125-139 fragment into binding assays, pull-down experiments, or surface plasmon resonance studies, scientists can characterize the affinity and specificity of interactions with endogenous inhibitors, cofactors, or regulatory proteins. These insights contribute to a deeper understanding of the regulatory mechanisms governing kallikrein activity in physiological and pathological contexts.
Antibody production and epitope mapping: The defined sequence of this peptide makes it a useful immunogen for generating polyclonal or monoclonal antibodies targeting kallikrein-4. Additionally, it can be applied in epitope mapping experiments to identify antibody binding sites, assess immune reactivity, or validate antibody specificity. Such applications are essential for developing robust immunoassays and advancing biomarker discovery efforts in research settings.
Analytical assay development: The 125-139 peptide fragment can be integrated into quantitative and qualitative analytical platforms, including enzyme-linked immunosorbent assays (ELISA), mass spectrometry-based detection, and immunoblotting protocols. Its use as a standard or calibrator supports the sensitive and specific measurement of kallikrein-4 levels, activity, or presence in complex biological samples. This capability is particularly valuable for basic research, biomarker validation, and the study of kallikrein-related signaling pathways.
Peptide structure-function studies: The synthetic peptide offers a controllable system for probing the structural determinants of kallikrein-4 function. By employing techniques such as nuclear magnetic resonance (NMR) spectroscopy, circular dichroism, or computational modeling, researchers can investigate the conformational properties, stability, and folding behavior of this region. These studies facilitate the identification of structural motifs essential for enzymatic activity, molecular recognition, or protein-protein interactions, thereby advancing the fundamental understanding of serine protease biology.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More